chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The appearance was of shingles; Rash along the medial aspect of my left breast / small amount on the lateral left breast; Rash has more of a scabbed appearance; This case was reported by a nurse and described the occurrence of shingles in a 53-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 8th February 2021, the patient received the 1st dose of Shingrix. On 13th February 2021, 5 days after receiving Shingrix and an unknown time after starting Valtrex, the patient experienced shingles and rash. In February 2021, the patient experienced scab. The patient was treated with valaciclovir hydrochloride (Valtrex). On an unknown date, the outcome of the shingles and rash were recovering/resolving and the outcome of the scab was unknown.   It was unknown if the reporter considered the shingles, rash and scab to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported but it could be 52 or 53 years old. The patient received the first dose of the Shingrix vaccine on 8th February 2021 (Monday). On the following Saturday (13th February 2021), she noted a rash along the medial aspect of left breast with a small amount also on the lateral left breast. As the reporter was a nurse who worked with breast cancer patients and, hence had concerns of inflammatory breast cancer, she went to see a breast specialist on 16th February 2021 (Tuesday). The breast specialist reassured her that the appearance was not that of inflammatory breast cancer but was rather of shingles.  The patient was prescribed Valtrex which she was taking and was on day 6 on the reporting date. The rash was clearing up but was still present at the time of reporting and had more of a scabbed appearance at that time. The reporter was wondering if this had been noted in any other patients with Shingrix and was also inquiring if she should receive the second dose. The reporter consented to follow -up.
Developed purple blisters biopsied as nutriphilic dermatitis Recurred with second booster from pfizer
No additional AE reported; Patient was administered expired MMRll; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender. No information about the patient's medical history, concomitant medications and concurrent conditions was reported.  On 17-JAN-2022, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (recombinant human albumin (rHA)) (M-M-R II) lot# S039309, expiration date: 04-DEC-2021 (dose, site and route of administration were not provided) for prophylaxis (expired product administered). No additional adverse event was reported (no adverse event).
patient received adose of MMR II via the intramuscular route; No adverse effects reported; This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. No information regarding patient's pertinent medical history, drug reactions or allergies and concomitant medications was reported.  On an unknown date, the patient was vaccinated with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II), intramuscularly (instead of subcutaneously), (dose, injection site, lot# and expiration date were not provided) for prophylaxis.  There was no adverse event reported.
Itchy, red, swelling the size of a dollar bill near the entrance of the vaccine.  It is over a week now and very slowly getting smaller.  Redness and itchy still about 1/2 the size.
8.6 yo patient received Kinrix; This case was reported by a nurse via call center representative and described the occurrence of inappropriate age at vaccine administration in a 8-year-old female patient who received DTPa-IPV (Kinrix) (batch number 2KL4K, expiry date 9th November 2023) for prophylaxis.   Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   Previously administered products included Dtap vaccine (4th dose received in 2015) and OPV vaccine (health care professional reported that in the past patient received Oral polio vaccine (OPV)).   On 4th August 2022, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On 4th August 2022, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 05-AUG-2022 Reporter's Comment: The reporter was a nurse. The reporter stated that patient was 8 years and 6 months old, patient received Kinrix vaccine. The patient received Kinrix vaccine as 5th dose of Dtap  The health care professional was escalated to 2nd line specialist, reported that Kinrix was patient 4th dose of polio. The reporter consented to follow up. Additional supportive information: The patient received Kinirix who was older than the indicated age which led to inappropriate age at vaccine administration.
Resident experienced vomiting and edema of the lips. The M.D prescribed benadryl.
Fatigue 12/24 for 24 hours, self resolved.  1/8- dizziness and nausea, have not sought treatment yet.
First reaction came after the shot on 04/15/2022.  Red blotches on my inner thighs.  Same reaction happened after receiving the booster on 09/19/2022 only more server then the one on 04/15/2022.  Dr. concluded  that the blotched was Small Vessel Vasculatis .  He strongly recommend not to have any more Covid shots.  I have photo's of my reaction but not sure how to send them.
About 10 days after the vaccine, I was feeling more fatigued more than usual. It was annoying but was not as severe as it was right after the vaccine. I also had a headache. I had a routine checkup with my doctor in April and she told me I was in afib. I had a cardiologist visit prior to receiving the vaccine and it shoed no signs of afib or any issues. Something did cause me to go into afib. I was referred back to my electro cardio physician because she felt I needed something to put me back in to sinus rhythm. On 6/6/21, I went in for an electro cardio conversion which was successful. I am also on a medication called Tikosyn. After this, my fatigue and malaise were gone. I am going to have a ?touch up? ablation on 10/1/21 to try and cease taking medication which I believe will be successful as well.
A report has been received from a Health Professional concerning an 11 year old, female subject, who had been receiving Nasal FLUMIST QUADRIVALENT. The reporter reported for 17 patients who had inadvertently administered expired FLUMIST. FLUMIST QUADRIVALENT (Intranasal) started on 27-Jan-2014. It was reported that the patient was inadvertently administered expired FLUMIST which started on 27-Jan-2014. The outcome of the event of expired FLUMIST is unknown. The report was considered to be non-serious.
Pain in arm was minimal but became very sleepy and developed headache Thursday evening following covid vaccine. Slept 10 hours.  03/05 sinus pain, headache worse.  03/06 slept most of the day. achy, lack of appetite, 03/07 no pain in arm but body aches and continued strong headache & fatigue.  Contacted Teledoc on 03/08,  Dr. suggestion Acute upper respiratory infection with secondary diagnosis serum reaction due to vaccination.  03/09 continued headache, chills, body aches, fatigue, ringing in ears fever (no working thermometer). Took Covid test, results due by Friday.  03/10 continued headache, fatigue, occasional chills, not able to smell, ears ringing.  Ibuprofen, Extra strength tylenol and Excedrin migraine not helping headache.
Patient was given his second dose of Pfizer 7 days too early, yesterday 4/22/21. Patient called PCP complaining of fever and increased heart rate today 4/22/21 and was seen by PCP at 1345. Patient woke up at 0400 this morning with symptoms stated. Patient was seen and evaluated by PCP, offered a COVID test to be sure- mother and patient declined test. We were instructed by Poison Control that patient is to make an appointment and receive another dose of Pfizer on date he was to originally receive the vaccine.
Moderna COVID-19 Vaccine.   After the expected fatigue, dysphoria and sleepiness from 12 hours to c. 36 hours after inoculation, I recovered in timely manner, but noticed my lower bowel with some gas, which terminated and eased with one episode of diarrhia on the third day after inoculation.  There was an unusual odor from the feces only then.  This occurred within my usual dietary regimen.  I did not experience any upper tract or gastric unpleasantness.  I did not have loss of appetite except as resulting from the general dysphoria of the immune response.        This response was mild and cleared quickly, but I thought it might be of interest; as it has never been mentioned publicly that I have heard.
Fever >102, vomiting w/in 4hr of vax w/accompanying lethargy;tx w/APAP, clear fluids;
Patient presented to pharmacy complaining of a rash/hives related to the vaccine. Body was generally splotchy but rash was fairly diffuse and not immediately obvious. Patient stated this started after her most recent dose of Moderna.
This was NOT an Adverse Event.  The vaccine was in freezer longer than 14 days.   The patient was advised to revaccinate per CDC.
Plaintiffs allege that as a result of vax in 1966 (specific vaccine manufacturer unk), pt sustained permanent brain damage & seizure disorder;
Chills lasted about 2 hours (14 hours after receiving vaccine). I woke up with a massive headache the following day, which lasted about 8-10 hours.
Information has been received from a physician concerning an 18 year old female patient with a history of alopecia who on 11-MAY-2010 was vaccinated intramuscularly with the first 0.5ml dose of GARDASIL (lot# 662529/1317Y). There was no concomitant medication. On 11-MAY-2010, the patient experienced "near syncope" after administration of GARDASIL. The patient sought medical attention in office. The patient was given soda and was monitored. There was no diagnostics studies performed. On 11-MAY-2010, the patient was fully recovered while in the office. Follow-up information has been received from the physician concerning the female patient who on 11-MAY-2010, at 7:00 PM was vaccinated IM with the first dose of GARDASIL (lot # 662529/1317Y). Concomitant therapy included MENACTRA (lot # 43433AA). There was no illness at time of vaccination. On 11-MAY-2010, at 7:15 PM, the patient experienced "near syncope" episode after vaccine administration. Her face turned pale, BP 132/86, P 60. Approximately 15 minutes later, the patient recovered after drinking soda. The patient did not seek medical attention (previously reported as sought medical attention in office). Additional information is not expected.
Headache; Nausea; extreme Diarrhea; This is a spontaneous report from a contactable consumer (patient). A 43-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EL3249), via an unspecified route of administration at the left arm on 21Jan2021 14:30 at a single dose for covid-19 immunization. The patient medical history includes chronic kidney disease. The patient was not pregnant from the time of administration. The patient was taking numerous unspecified medications. The patient previously took amoxicillin sodium;clavulanate potassium (AUGMENTIN) and experienced allergy. On 21Jan2021 at 04:30 PM the patient experienced headache, nausea and extreme diarrhea. The events were assessed as non-serious, did not result in death, not life threatening, did not cause/prolonged hospitalization, not disabling/incapacitating, did not cause congenital anomaly/birth defect. Treatment was not received for the adverse events. The vaccine was administered in doctor's office/urgent care. The patient has not received any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination the patient has not been tested for COVID-19. The outcome of the events was unknown.
This spontaneous report was received from a Registered Nurse (R.N.) concerning a 14 year old male patient. No concurrent conditions or medical history were reported. On an unknown date, the patient was vaccinated with his first dose of GARDASIL 9 (dose, lot #, expiration date and route were not reported) and then, on unspecified date, received his second dose of GARDASIL (Lot No., expiration date, dose, route and anatomical location of administration were not reported). No adverse effect reported. It was unknown if the patient sought medical attention. No product quality complaint was involved. At the time of the report, the outcome of interchange of vaccine products was unknown. Additional information has been requested.
2 1/2 year old male c/o swelling and redness with itching on day #2 (after flu shot) around injection site. No tenderness or other complaints. 10x8cm erythematous swelling and warm/itchy rash around left upper arm.
This case was reported by a nurse and described the occurrence of injection site redness in a 2-month-old male subject who was vaccinated with diphtheria and tetanus toxoids and acellular pertussis adsorbed, hepatitis B recombinant and inactivated poliovirus vaccine combined (Pediarix) for prophylaxis. Previous and/or concurrent vaccination included Haemophilus influenzae type b vaccine given on 19 July 2006; pneumococcal vaccine, unspecified (Prevnar) given on 19 July 2006. The subject's mother thought that the subject had a milk allergy since he was born due to reactions in the past such as cramping, vomiting, fussy, and gassy which occurred with milk, therefore, the subject's mother had completely eliminated milk from her diet because she was breastfeeding. There were no concurrent medications. On 19 July 2006 at 15:15, the subject received the 1st dose of Pediarix (unknown, right thigh). On 19 July 2006, at an unspecified time after vaccination with Pediarix, the subject experienced injection site redness and swelling. On 20 July 2006, the subject experienced cramping, vomiting, fussy, and gassy. The nurse called to report that the subject had symptoms similar to symptoms he has after ingesting milk. The subject's mother thought that the stomach symptoms were due to Pediarix since she read that Pediarix has bovine casein. The events of injection site redness and swelling resolved on an unspecified date in July 2006. The nurse considered the events were probably related to vaccination with Pediarix. At the time of reporting, cramping, vomiting, fussy, and gassy were unresolved. The physician did not think that the stomach symptoms were related to Pediarix. Follow-up received on 10 August 2006 from the nurse indicated that the symptoms resolved on 20 July 2006.
went back into Afib.; This spontaneous case was reported by a consumer and describes the occurrence of ATRIAL FIBRILLATION (went back into Afib.) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028L20A, 016M20A and 027C21A) for COVID-19 vaccination.     The patient's past medical history included Atrial fibrillation and Heart valve replacement. Concomitant products included TACROLIMUS (PROGRAF), BUPROPION HYDROCHLORIDE (WELLBUTRIN), LEVOTHYROXINE SODIUM (SYNTHROID), LINAGLIPTIN (TRADJENTA), MORNIFLUMATE (FLOMAX [MORNIFLUMATE]), ROSUVASTATIN, AMLODIPINE, POLYCARBOPHIL CALCIUM (FIBER), ASPIRIN [ACETYLSALICYLIC ACID] and VITAMINS NOS for an unknown indication.   On 02-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 10-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 11-Aug-2021, the patient experienced ATRIAL FIBRILLATION (went back into Afib.) (seriousness criterion medically significant). The patient was treated with WARFARIN for Atrial fibrillation, at an unspecified dose and frequency and METOPROLOL for Atrial fibrillation, at an unspecified dose and frequency. At the time of the report, ATRIAL FIBRILLATION (went back into Afib.) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   On the day after receiving the third shot, he went into Afib again. Husband is scheduled for a chock on Friday.  This case concerns a 70 year-old male patient with medical history of atrial fibrillation and heart value replacement x2, who experienced the unexpected serious event of Atrial fibrillation. The event occurred 1 day after the third dose of mRNA-1273 vaccine. The event is Medically significant based on reported treatment with medications. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.   Reporter did not allow further contact; Sender's Comments: This case concerns a 70 year-old male patient with medical history of atrial fibrillation and heart value replacement x2, who experienced the unexpected serious event of Atrial fibrillation. The event occurred 1 day after the third dose of mRNA-1273 vaccine. The event is Medically significant based on reported treatment with medications. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.
Diabetic patient with normal glucose readings between 120-190 reported having continuous readings of 280-400 for 10 days after booster (moderns).  Days 11-14, the glucose levels reduced to 220-280.  Patient is now taking Basaglar to reduce glucose levels.  Unknown if insulin is reducing levels, or if the side effects of the vaccine booster have worn off .
8 days, post vax, pt developed a fever and rash. Rash covered entire body. By 11 days, post vax, she developed petechia. Idiopathic thrombocytopenia purpura was dx'd. Platelet count was better by 10/11/00.
Patient was seen by their PCP and given a flu shot. Patient then presented to the urgent care with his wife, who stated "I need a flu shot for me and my husband." Patient was given a flu shot by our clinical staff. As I was reviewing the note from our clinical staff, I recognized that the patient had already received a flu shot. Patient and his wife were contacted by the urgent care manager and was told to notify us if any issues arise.
fast heart beat of 100 beats per minute; fever of 101.6 degrees Fahrenheitfever fluctuating between 99 and 101 F; chills/could not get warm; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (fast heart beat of 100 beats per minute), PYREXIA (fever of 101.6 degrees Fahrenheitfever fluctuating between 99 and 101 F) and CHILLS (chills/could not get warm) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 020B21A and 020B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included NAPROXEN SODIUM (COMPLEMENT) for an unknown indication.   On 14-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-May-2021, the patient experienced HEART RATE INCREASED (fast heart beat of 100 beats per minute), PYREXIA (fever of 101.6 degrees Fahrenheitfever fluctuating between 99 and 101 F) and CHILLS (chills/could not get warm). At the time of the report, HEART RATE INCREASED (fast heart beat of 100 beats per minute) outcome was unknown and PYREXIA (fever of 101.6 degrees Fahrenheitfever fluctuating between 99 and 101 F) and CHILLS (chills/could not get warm) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 13-May-2021, Body temperature: 101.6 (High) fever of 101.6 degrees Fahrenheit. On 13-May-2021, Heart rate: High.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications includes Multivitamins for Vegans along with above mentioned medication. No treatment drugs were reported.
Evening of 7th day after shot red circle at injection site.  Morning of 8th day felt like bruise near collar bone on left side and injection site swelling and redness and itching.  Afternoon of 8th day "rash" started at collar bone with heat and itching going toward neck.  Dr. prescribed antibiotics and took Benadryl.  Went for scheduled 2nd dose and was denied until seeing allergist.  Went to Dr and was ok'd to receive 2nd dose.
CLIENT REPORTED NAUSEA, FEVER, HALLUCINATIONS, AND SEVERE JOINT PAIN. CLIENT ALSO STATED "I HAD EVERY REACTION YOU COULD HAVE LISTED ON THAT PIECE OF PAPER SHORT OF ANAPHYLAXIS."
I am a breastfeeding mother. i had minor covid symptoms after vaccination. my daughter is 10 months old.  2.5 days after receiving the vaccine she developed a fever of 103 which decreased to 100 with tylenol given regularly. her fever lasted 36 hours. when I had covid in January she did not develop a fever.
Patient received COVID-19 Moderna. She waited at the clinic site for approximately 20 minutes after  administration. She left approximately ten minutes later felt her face get hot. She noticed her face was  flushing. She noticed tachycardia and some chest tightness while driving. She continued on her errands  and began feeling better by 4PM. She reports she did not feel completely better until approximately  8PM.
22w pregnant, EDD 9/28/21, began having allergy-like symptoms to include runny nose, postnasal drip, sore throat, and watery eyes that progressed to a fever, severe congestion, sneezing, malaise, headaches, cold symptoms.
Summary: Extreme cramps followed by abdomen bloating and passing a lot of blood.  Details: Sudden onset of extreme stomach cramps at 2 AM lasting a few hours without passing anything.  Stomach became very bloated.  Then suddenly passed a lot of blood (no stool) which continued and lessened over the next 2-1/2 days.  (This was not caused by external physical injury.)  Was put on an IV for fluids during ER visit and hospitalization before tests and scan. Scans and tests were not done until well after initial event and entry into the ER by which time pain had mostly abated and swelling had somewhat reduced. CT Scans were done more than 20 hours after event began and after bleeding and bloating had already reduced, but still indicated inflamed and swollen colon or intestine. Doctors said it was colitis, but no reason given.  Bloating of stomach mostly abated and bleeding coming out of rectum was negligible when discharged from hospital about 60 hours after it started. (Note: patient also has a different reported event on 4/16/2021 soon after second dose.)